Portland, OR -- (SBWIRE) -- 08/18/2017 -- Western blotting is a technique used widely to detect and analyze proteins. Due to its high sensitivity and automated processing, it offers great help in detection and diagnosis of various diseases.

Increasing prevalence of HIV globally that expands the application of western blotting in the field of proteomics and increased investments in R&D by various pharmaceuticals and biotechnology companies are major factors that lead to increased demand for western blotting. However, expensive instruments, high costs of primary antibodies, time factor, emergence of alternative technologies, and the demand for skilled labor in equipment handling are the major restraining factors of this technology.

Access full summary at: https://www.alliedmarketresearch.com/western-blotting-market

This global market is segmented based on technology, application, and geography. Based on technology this market is segmented into instruments and consumables. Based on application it is segmented into biomedical and biochemical research, disease diagnostics, and agriculture. This report geographically covers North America, Europe, Asia-Pacific, and LAMEA.

Request Report Sample: https://www.alliedmarketresearch.com/request-toc-and-sample/2821

The key market players covered in this report include Thermo-Fisher Scientific Inc., F.Hoffmann-La Roche Ltd., DANAHER, Amicon ultra (EMD Millipore Corporation), Bio-Rad Laboratories, Inc., PerkinElmer Inc., LI-COR, Inc., Bio-Techne Corporation, and ADVANSTA Inc.

Western Blotting Market Key Segments:

By Technology

- Instruments
- Gel Electrophoresis Instruments
- Blotting Systems
- Semi-Dry Blotting Instruments
- Wet Blotting Instruments

- Imagers
- Chemiluminescent Imagers
- Fluorescent Imagers
- Others

- Consumables
- Reagents
- Kits

- By Application

- Biomedical & Biochemical Research
- Disease Diagnostics
- Agriculture